189 related articles for article (PubMed ID: 8925528)
1. [Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
Schwartz PJ
Cardiologia; 1996 Aug; 41(8):739-45. PubMed ID: 8925528
[No Abstract] [Full Text] [Related]
2. [Role of antiarrhythmics in the post-infarction period].
Dinanian S
Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
[TBL] [Abstract][Full Text] [Related]
3. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Alboni P
Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
[TBL] [Abstract][Full Text] [Related]
4. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
Baum T; Peters JR; Eckfeld DK; Varner LL; Dinish J; Metz N; Shropshire AT
Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
[No Abstract] [Full Text] [Related]
5. [Improved prognosis using beta blockers after myocardial infarct?].
Weisswange A
Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
[No Abstract] [Full Text] [Related]
6. Cardiac death prevention in post-myocardial infarction patients: a review.
Boissel JP; Leizorovicz A; Faucomprez C
Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
[No Abstract] [Full Text] [Related]
7. [Secondary prevention of myocardial infarct].
Kotsev G
Vutr Boles; 1984; 23(2):55-9. PubMed ID: 6146228
[No Abstract] [Full Text] [Related]
8. [Anti-arrythmic effects of DL-propranolol, D-propranolol and I.C.I.50 172 in experimental myocardial infarction in dogs].
Staszewska-Barczak J
Acta Physiol Pol; 1970; 21(3):317-29. PubMed ID: 4393011
[No Abstract] [Full Text] [Related]
9. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
Mitchell LB
J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
[No Abstract] [Full Text] [Related]
10. [Nifedipine in the therapy of myocardial infarct in patients over 70].
Ziacchi V; Rossi A; Lomanto B
Minerva Cardioangiol; 1982 Apr; 30(4):163-9. PubMed ID: 6123963
[No Abstract] [Full Text] [Related]
11. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
[TBL] [Abstract][Full Text] [Related]
12. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
[TBL] [Abstract][Full Text] [Related]
13. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
Konecná P; Dvorák R; Semrád B
Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
[TBL] [Abstract][Full Text] [Related]
14. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
[TBL] [Abstract][Full Text] [Related]
15. Class III antiarrhythmic agents: the next wave.
Bauman JL
Pharmacotherapy; 1997; 17(2 Pt 2):76S-83S; discussion 89S-91S. PubMed ID: 9085343
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia.
Kovoor P; Love A; Hall J; Kruit R; Sadick N; Ho D; Adelstein BA; Ross DL
Intern Med J; 2005 Sep; 35(9):518-25. PubMed ID: 16105152
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic properties of beta-blockers.
Haverkamp W; Hindricks G; Gülker H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S29-32. PubMed ID: 11527133
[TBL] [Abstract][Full Text] [Related]
18. Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.
Hagens VE; Rienstra M; Van Veldhuisen DJ; Crijns HJ; Van Gelder IC
Am J Cardiol; 2006 Oct; 98(7):929-32. PubMed ID: 16996876
[TBL] [Abstract][Full Text] [Related]
19. A randomised cross-over study on the haemodynamic effects of oral dofetilide compared with oral sotalol in patients with ischaemic heart disease and sustained ventricular tachycardia.
Boriani G; Biffi M; Bacchi L; Martignani C; Zannoli R; Butrous GS; Branzi A
Eur J Clin Pharmacol; 2002 Jun; 58(3):165-9. PubMed ID: 12107600
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
